As of close of business last night, Rocket Pharmaceuticals Inc’s stock clocked out at $29.30, up 0.93% from its previous closing price of $29.03. In other words, the price has increased by $+0.27 from its previous closing price. On the day, 1279487 shares were traded.
Ratios:
To gain a deeper understanding of RCKT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.80 and its Current Ratio is at 7.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on October 24, 2023, initiated with a Overweight rating and assigned the stock a target price of $65.
On February 01, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $53.Canaccord Genuity initiated its Buy rating on November 08, 2022, with a $53 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 16 when Shah Gaurav sold 20,272 shares for $29.84 per share. The transaction valued at 604,876 led to the insider holds 554,762 shares of the business.
Patel Kinnari sold 7,132 shares of RCKT for $212,805 on Feb 16. The insider now owns 238,346 shares after completing the transaction at $29.84 per share. On Feb 16, another insider, Wilson Martin, who serves as the General Counsel of the company, sold 3,576 shares for $29.84 each. As a result, the insider received 106,701 and left with 6,136 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 2.62B and an Enterprise Value of 2.21B.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $14.89. The 50-Day Moving Average of the stock is 28.96, while the 200-Day Moving Average is calculated to be 22.12.
Shares Statistics:
It appears that RCKT traded 848.86K shares on average per day over the past three months and 756.55k shares per day over the past ten days. A total of 90.28M shares are outstanding, with a floating share count of 82.34M. Insiders hold about 8.67% of the company’s shares, while institutions hold 95.84% stake in the company. Shares short for RCKT as of Feb 15, 2024 were 9.2M with a Short Ratio of 10.84, compared to 8.25M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.19% and a Short% of Float of 13.28%.
Earnings Estimates
As of right now, 10 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.7 for the current quarter, with a high estimate of -$0.5 and a low estimate of -$0.85, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.49 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$0.91 and -$3.38 for the fiscal current year, implying an average EPS of -$2.64. EPS for the following year is -$1.98, with 10 analysts recommending between -$0.5 and -$3.17.
Revenue Estimates
Based on 9 analysts’ estimates, the company’s revenue will be $174.37M in the next fiscal year. The high estimate is $325.82M and the low estimate is $23.1M. The average revenue growth estimate for next year is up 752.20% from the average revenue estimate for this year.
